SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-032036
Filing Date
2020-03-12
Accepted
2020-03-11 17:53:44
Documents
6
Period of Report
2020-03-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2012380d1_8k.htm 8-K 24676
2 EXHIBIT 1.1 tm2012380d1_ex1-1.htm EX-1.1 233632
3 EXHIBIT 5.1 tm2012380d1_ex5-1.htm EX-5.1 12292
4 EXHIBIT 99.1 tm2012380d1_ex99-1.htm EX-99.1 9262
5 GRAPHIC tm2012380d1_ex5-1img01.jpg GRAPHIC 1910
6 GRAPHIC tm2012380d1_ex5-1img02.jpg GRAPHIC 6469
  Complete submission text file 0001104659-20-032036.txt   292892
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 20706482
SIC: 2834 Pharmaceutical Preparations